Overview
Also known as:
FDA & Trial Timeline
1 eventInfumorph: FDA approved
For intrathecal or epidural infusion in the treatment of tractable chronic pain. It was developed for use in continuous microinfusion devices and may require dilution before use as directed.
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
1 availableInfumorph
For intrathecal or epidural infusion in the treatment of tractable chronic pain. It was developed for use in continuous microinfusion devices and may require dilution before use as directed.
Clinical Trials
View all trials with filters →No actively recruiting trials found for Hypertension due to gain-of-function mutations in the mineralocorticoid receptor at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Hypertension due to gain-of-function mutations in the mineralocorticoid receptor.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hypertension due to gain-of-function mutations in the mineralocorticoid receptor.
Community
No community posts yet. Be the first to share your experience with Hypertension due to gain-of-function mutations in the mineralocorticoid receptor.
Start the conversation →Latest news about Hypertension due to gain-of-function mutations in the mineralocorticoid receptor
No recent news articles for Hypertension due to gain-of-function mutations in the mineralocorticoid receptor.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hypertension due to gain-of-function mutations in the mineralocorticoid receptor
What treatment and support options exist for Hypertension due to gain-of-function mutations in the mineralocorticoid receptor?
1 patient support program are currently tracked on UniteRare for Hypertension due to gain-of-function mutations in the mineralocorticoid receptor. See the treatments and support programs sections for copay assistance, eligibility, and contact details.